ABILITY Neurotech
ABILITY Neurotech is an Invasive Cortical Implants company founded in 2025 and based in Geneva, Switzerland.
Founded in 2025 and headquartered in Geneva, Switzerland, ABILITY Neurotech builds the ABILITY BCI System, a fully implantable, battery-free brain-computer interface for restoring communication and motor function in patients with severe paralysis. The system uses high-density ECoG electrodes to capture broadband neural signals from the cortex and transmits them wirelessly through intact skin via a proprietary laser-based optical data link achieving 50 Mb/s data transmission. Real-time AI decoding reconstructs intended speech and movement, designed as a complete platform spanning neural signal capture, processing, and clinical integration for patients with ALS, spinal cord injury, and stroke.
ABILITY Neurotech operates in the invasive cortical implants sector of brain-computer interfaces, targeting severe neurological conditions where restoration of communication and motor function represents a significant unmet clinical need. The company's proprietary wireless transmission technology and battery-free design distinguish its engineering approach within the BCI category. Spun from the Wyss Institute Geneva, the company brings institutional research backing and co-founder expertise to a frontier medical device domain.
abilityneuro.com ↗·Invasive Cortical Implants·
Switzerland·private 
